Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors
Crossref DOI link: https://doi.org/10.1007/s00432-014-1754-8
Published Online: 2014-07-18
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhu, Xiaodong
Zhao, Xiaoying
Peng, Wei
Sun, Si
Cao, Jun
Ji, Dongmei
Liu, Xin
Wang, Chenchen
Huang, Mingzu
Yu, Hui
Guo, Weijian
Li, Jin
Yin, Jiliang
Text and Data Mining valid from 2014-07-18